• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: LUTONIX, INC LUTONIX 035AV DRUG COATED PTA DILATION CATHETER; DRUG COATED BALLOON PTA CATHETER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

LUTONIX, INC LUTONIX 035AV DRUG COATED PTA DILATION CATHETER; DRUG COATED BALLOON PTA CATHETER Back to Search Results
Model Number 9010
Medical Device Problem Code Adverse Event Without Identified Device or Use Problem (2993)
Health Effect - Clinical Codes Restenosis (4576); Swelling/ Edema (4577)
Date of Event 09/01/2023
Type of Reportable Event Serious Injury
Event or Problem Description
It was reported through the results of a clinical trial that one year and twenty-two days post an index procedure completion using a drug-coated balloon catheter in the basilic vein at swing point, the subject developed a serious adverse event of left upper extremity swelling and stenosis of index lesion due to arm swelling which required an arteriovenous access circuit reintervention.It was further reported that the target lesion was in the upper arm with seventy percent initial stenosis and ten percent final residual stenosis.Standard percutaneous transluminal balloon angioplasty procedure was performed to treat arm swelling.Treatment re-intervention was successful, no new access created, and the outcome of the serious adverse event was resolved.Reportedly, there have been no documented device deficiencies and no secondary stage procedures were reported for this subject to date.The current status of the patient is unknown.
 
Additional Manufacturer Narrative
H10: as the lot number for the device was provided, a review of the device history records will be performed.The sample was not returned to the manufacturer for inspection/evaluation.Therefore, the investigation of the reported event is inconclusive.Based upon the available information, the definitive root cause for this event is unknown.The instructions for use (ifu) is adequate for the reported device/patient code(s) and provides general instructions for use, as well as warnings, precautions and potential complications associated with the device.Upon receipt of new or additional information, a follow-up report will be submitted as applicable.H10: d4 (expiration date: 02/2024).H11: section a through f ¿ the information provided by bd represents all the known information at this time.Despite good faith efforts to obtain additional information, the complainant/reporter was unable or unwilling to provide any further patient, product, or procedural details to bd.H3 other text : device not returned.
 
Additional Manufacturer Narrative
H10: manufacturing review: a manufacturing review was not required as this is the only complaint reported to date for this product and lot.Investigation summary: the physical device was not returned for evaluation.No photos were provided for review.Therefore, the investigation is inconclusive for the reported failure as no objective evidence was provided for review.Based upon the available information, the definitive root cause is unknown.Labeling review: as the reported event did not allege a labeling or use related issue, a labeling review is not required.D4 (expiration date: 02/2024), h6 (patient, method).H11: section a through f ¿ the information provided by bd represents all the known information at this time.Despite good faith efforts to obtain additional information, the complainant/reporter was unable or unwilling to provide any further patient, product, or procedural details to bd.
 
Event or Problem Description
It was reported through the results of a clinical trial that one year and twenty-two days post an index procedure completion using a drug-coated balloon catheter in the basilic vein at swing point, the subject developed a serious adverse event of left upper extremity swelling and stenosis of index lesion due to arm swelling which required an arteriovenous access circuit reintervention.It was further reported that the target lesion was in the upper arm with seventy percent initial stenosis and ten percent final residual stenosis.Standard percutaneous transluminal balloon angioplasty procedure was performed to treat arm swelling.Treatment re-intervention was successful, no new access created, and the outcome of the serious adverse event was resolved.Reportedly, there have been no documented device deficiencies and no secondary stage procedures were reported for this subject to date.The current status of the patient is unknown.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
LUTONIX 035AV DRUG COATED PTA DILATION CATHETER
Common Device Name
DRUG COATED BALLOON PTA CATHETER
Manufacturer (Section D)
LUTONIX, INC
9409 science center dr
new hope MN 55428
Manufacturer (Section G)
C.R. BARD, INC. (GFO)
289 bay road
queensbury 12804
Manufacturer Contact
brett curtice
800 w. rio salado pkwy
tempe, AZ 85281
4803032689
MDR Report Key18874451
Report Number3006513822-2024-00010
Device Sequence Number9049641
Product Code PRC
UDI-Device Identifier00801741135491
UDI-Public(01)00801741135491
Combination Product (Y/N)N
Initial Reporter StateLA
Initial Reporter CountryUS
PMA/510(K) Number
P170003
Number of Events Summarized1
Summary Report (Y/N)N
Reporter Type Manufacturer
Report Source Other,Study
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 06/15/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Model Number9010
Device Catalogue NumberLX3575960V
Device Lot NumberGFFZ1878
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Follow-Up
Initial Date Received by Manufacturer 02/13/2024
Supplement Date Received by Manufacturer06/17/2024
Initial Report FDA Received Date03/11/2024
Supplement Report FDA Received Date06/29/2024
Was Device Evaluated by Manufacturer? (Y/N) No
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention;
Patient Age68 YR
Patient SexMale
Patient Weight93 KG
Patient EthnicityNon Hispanic
Patient RaceBlack Or African American
-
-